Product Wiki · Recalls · EU Safety Gate (RAPEX)

Crème de Visage Éclaircissante, Mahéeda Divine, 100grs — recall SR/01534/25

EU Safety Gate (RAPEX) · Sweden · 2025-04-25 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01534/25
Date of alert
2025-04-25
Country / jurisdiction
Sweden
Risk level
Serious risk
Risk type
Chemical
Product category
Cosmetics
Product type
Skin lightening cream
Barcode (EAN/GTIN)
6186000026173
Reported risk: Produkten innehåller hydrokinon, som är förbjudet i denna kosmetiska produkt. Hydrokinon kan orsaka allergisk hudreaktion, kan orsaka cancer och orsakar allvarliga ögonskador. Produkten uppfyller inte kraven i kosmetikförordningen.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Importer
Category of measure
Import rejected at border
Date of entry into force
09/04/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Crème de Visage Éclaircissante, Mahéeda Divine, 100grs

Risk Description (original English): The product contains hydroquinone, which is prohibited in this cosmetic product. Hydroquinone may cause an allergic skin reaction, can cause cancer and causes serious eye damage.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10094091

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.